Based on UALCAN database, LMAN2 mRNA expression exhibited a significant positive link to the clinicopathological characteristics, including clinical stage, race, sex, p53 mutation status, age, cancer subclasses, distant metastases, and menopause (p < 0.05) (Figure 2(a)). This evidence concerns the gene LMAN2 and cancer.